Sun Pharmaceutical Industries Ltd.

The Revenue for the quarter ended  June 2025 of Rs. 56019.60 millions grew by 24.54 % from Rs. 44980.70 millions.The Total revenue for the quarter ended June 2025 of  Rs. 7535.30  millions  grew by 216.85% from Rs. 2378.20 millions.Operating profit for the quarter ended June 2025 rose to 19948.40 millions as compared to 8438.10 millions of corresponding quarter ended June 2024.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202506	202406	% Var	202506	202406	% Var	202503	202403	% Var
Sales	56019.60	44980.70	24.54	56019.60	44980.70	24.54	230033.30	202751.70	13.46
Other Income	2932.10	827.40	254.38	2932.10	827.40	254.38	6239.70	4657.60	33.97
PBIDT	19948.40	8438.10	136.41	19948.40	8438.10	136.41	71620.50	60533.70	18.32
Interest	2232.90	2160.80	3.34	2232.90	2160.80	3.34	8932.10	7840.80	13.92
PBDT	14839.10	6277.30	136.39	14839.10	6277.30	136.39	62688.40	50502.70	24.13
Depreciation	2990.30	3698.10	-19.14	2990.30	3698.10	-19.14	12382.70	16006.20	-22.64
PBT	11848.80	2579.20	359.40	11848.80	2579.20	359.40	50305.70	34496.50	45.83
TAX	4313.50	201.00	2046.02	4313.50	201.00	2046.02	7479.50	5914.70	26.46
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	7535.30	2378.20	216.85	7535.30	2378.20	216.85	42826.20	28581.80	49.84
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	35.61	18.76	89.82	35.61	18.76	89.82	31.13	29.86	4.28